JP2023526310A5 - - Google Patents

Info

Publication number
JP2023526310A5
JP2023526310A5 JP2022569265A JP2022569265A JP2023526310A5 JP 2023526310 A5 JP2023526310 A5 JP 2023526310A5 JP 2022569265 A JP2022569265 A JP 2022569265A JP 2022569265 A JP2022569265 A JP 2022569265A JP 2023526310 A5 JP2023526310 A5 JP 2023526310A5
Authority
JP
Japan
Prior art keywords
mir
target sequences
sequence
raav
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022569265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526310A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/032003 external-priority patent/WO2021231579A1/en
Publication of JP2023526310A publication Critical patent/JP2023526310A/ja
Publication of JP2023526310A5 publication Critical patent/JP2023526310A5/ja
Pending legal-status Critical Current

Links

JP2022569265A 2020-05-12 2021-05-12 導入遺伝子発現のdrg特異的低減のための組成物 Pending JP2023526310A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063023593P 2020-05-12 2020-05-12
US63/023,593 2020-05-12
US202063038488P 2020-06-12 2020-06-12
US63/038,488 2020-06-12
US202063043562P 2020-06-24 2020-06-24
US63/043,562 2020-06-24
US202063079299P 2020-09-16 2020-09-16
US63/079,299 2020-09-16
US202163152042P 2021-02-22 2021-02-22
US63/152,042 2021-02-22
PCT/US2021/032003 WO2021231579A1 (en) 2020-05-12 2021-05-12 Compositions for drg-specific reduction of transgene expression

Publications (2)

Publication Number Publication Date
JP2023526310A JP2023526310A (ja) 2023-06-21
JP2023526310A5 true JP2023526310A5 (cg-RX-API-DMAC7.html) 2024-05-22

Family

ID=76532231

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569265A Pending JP2023526310A (ja) 2020-05-12 2021-05-12 導入遺伝子発現のdrg特異的低減のための組成物

Country Status (12)

Country Link
US (1) US20230304034A1 (cg-RX-API-DMAC7.html)
EP (1) EP4162059A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023526310A (cg-RX-API-DMAC7.html)
KR (1) KR20230010670A (cg-RX-API-DMAC7.html)
CN (1) CN115803064A (cg-RX-API-DMAC7.html)
AU (1) AU2021270447A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022022212A2 (cg-RX-API-DMAC7.html)
CA (1) CA3177407A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022017959A2 (cg-RX-API-DMAC7.html)
IL (1) IL298138A (cg-RX-API-DMAC7.html)
MX (1) MX2022014258A (cg-RX-API-DMAC7.html)
WO (1) WO2021231579A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022036220A1 (en) * 2020-08-14 2022-02-17 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
AU2022262771A1 (en) 2021-04-23 2023-11-02 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
US20240384298A1 (en) 2021-10-02 2024-11-21 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
TW202340467A (zh) 2022-01-10 2023-10-16 賓州大學委員會 有用於治療c9orf72介導之病症之組成物及方法
CA3247109A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Compositions and treatment methods for metastatic breast cancer that is human epidermal growth factor receptor 2 positive and other cancers
US20250250326A1 (en) 2022-04-06 2025-08-07 The Trustees Of The University Of Pennsylvania Passive immunization with anti-aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
WO2024008949A1 (en) * 2022-07-08 2024-01-11 Sensorion REGULATORY SEQUENCES COMPRISING MicroRNA TARGET SITES
WO2024015966A2 (en) 2022-07-15 2024-01-18 The Trustees Of The University Of Pennsylvania Recombinant aav having aav clade d and clade e capsids and compositions containing same
WO2025007046A1 (en) 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
IL326390A (en) 2023-08-10 2026-04-01 Univ Pennsylvania Compositions and methods for treatment of spinal muscular atrophy
WO2026151888A1 (en) 2025-01-08 2026-07-16 The Trustees Of The University Of Pennsylvania Compositions for treating friedreich's ataxia

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
DK2002003T3 (en) * 2005-05-27 2016-03-21 Ospedale San Raffaele Srl Gene vector comprising miRNA
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
US20070027438A1 (en) 2005-07-26 2007-02-01 Frieder Loesel System and method for compensating a corneal dissection
DK3246403T3 (da) 2005-10-18 2020-10-26 Prec Biosciences Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
ES2422291T3 (es) 2007-10-31 2013-09-10 Prec Biosciences Inc Meganucleasas monocatenarias diseñadas racionalmente con secuencias de reconocimiento no palindrómicas
EP2315779A2 (en) 2008-07-09 2011-05-04 Biogen Idec MA Inc. Compositions comprising antibodies to lingo or fragments thereof
JP2011527906A (ja) 2008-07-14 2011-11-10 プレシジョン バイオサイエンシズ,インク. I−CreI由来メガヌクレアーゼの認識配列およびその使用
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
WO2011126808A2 (en) 2010-03-29 2011-10-13 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
DK2561073T3 (en) 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
KR20220025112A (ko) 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
EA037448B1 (ru) 2012-06-08 2021-03-30 Этрис Гмбх Способ доставки в легкие терапевтической мрнк с pei и фармацевтическая композиция
WO2014125647A1 (ja) 2013-02-18 2014-08-21 富士通オプティカルコンポーネンツ株式会社 光受信装置
BR112015021036A2 (pt) 2013-03-15 2017-10-10 Univ Pennsylvania composições e métodos para tratar mps1
FR3004463A1 (fr) * 2013-04-11 2014-10-17 Genethon Systeme d'expression pour une therapie genique selective
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
BR112016020688B1 (pt) 2014-03-09 2024-01-30 The Trustees Of The University Of Pennsylvania Vetores virais recombinantes, vírus adenoassociado recombinante, composição farmacêutica, bem como uso dos mesmos
US11555059B2 (en) 2014-04-25 2023-01-17 The Trustees Of The University Of Pennsylvania LDLR variants and their use in compositions for reducing cholesterol levels
WO2015164723A1 (en) 2014-04-25 2015-10-29 The Trustees Of The University Of Pennsylvania Methods and compositions for treating metastatic breast cancer and other cancers in the brain
WO2016049230A1 (en) 2014-09-24 2016-03-31 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
US11135313B2 (en) 2015-10-28 2021-10-05 The Trustees Of The University Of Pennsylvania Intrathecal administration of adeno-associated-viral vectors for gene therapy
EP3387138B2 (en) 2015-12-11 2026-05-27 The Trustees Of The University Of Pennsylvania Scalable purification method for aav9
WO2017106326A1 (en) 2015-12-14 2017-06-22 The Trustees Of The University Of Pennsylvania Aav-anti pcsk9 antibody constructs and uses thereof
AU2016370590B2 (en) 2015-12-14 2023-11-02 The Trustees Of The University Of Pennsylvania Composition for treatment of Crigler-Najjar syndrome
AU2016370630B2 (en) 2015-12-14 2023-04-13 The Trustees Of The University Of Pennsylvania Adeno-associated viral vectors useful in treatment of spinal muscular atropy
MA43968A (fr) 2016-02-03 2018-12-12 Univ Pennsylvania Thérapie génique pour traiter la mucopolysaccharidose de type i
PE20181922A1 (es) 2016-04-15 2018-12-11 Univ Pennsylvania Terapia genica para tratar la hemofilia a
US11253612B2 (en) 2016-04-15 2022-02-22 The Trustees Of The University Of Pennsylvania Gene therapy for treating mucopolysaccharidosis type II
US11191847B2 (en) 2016-04-15 2021-12-07 The Trustees Of The University Of Pennsylvania Gene therapy for treating hemophilia B
RS65241B1 (sr) 2017-02-28 2024-03-29 Univ Pennsylvania Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
EP4269596A3 (en) 2017-04-21 2024-02-14 Precision Biosciences, Inc. Engineered meganucleases specific for recognition sequences in the pcsk9 gene
BR112019023303A2 (pt) 2017-05-11 2020-06-16 The Trustees Of The University Of Pennsylvania Terapia de gene para lipofuscinoses ceroides neuronais
EP3635122A4 (en) * 2017-06-06 2021-03-31 University of Massachusetts SELF-REGULATING AAV VECTORS FOR THE SAFE EXPRESSION OF MECP2 IN RETT SYNDROME
US11555206B2 (en) 2017-11-30 2023-01-17 The Trustees Of The University Of Pennsylvania Gene therapy for mucopolysaccharidosis IIIA
EA202091352A1 (ru) 2017-11-30 2020-08-27 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Генотерапия мукополисахаридоза iiib
MX2021007600A (es) * 2018-12-21 2021-08-11 Univ Pennsylvania Composiciones para la reduccion de la expresion transgenica especifica de drg.
WO2020219766A1 (en) * 2019-04-24 2020-10-29 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of rett syndrome
JP7715640B2 (ja) * 2019-05-03 2025-07-30 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異染性白質ジストロフィーの治療に有用な組成物
JP7697943B2 (ja) * 2019-10-23 2025-06-24 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 導入遺伝子発現のdrg特異的低減のための組成物

Similar Documents

Publication Publication Date Title
JP2022517174A5 (cg-RX-API-DMAC7.html)
JP7248760B2 (ja) 肝特異的核酸調節要素ならびにその方法および用途
KR102526711B1 (ko) 고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
US20220249705A1 (en) Novel aav capsids and compositions containing same
Gardlík et al. Vectors and delivery systems in gene therapy
CA2904156C (en) Vectors comprising stuffer/filler polynucleotide sequences and methods of use
Tal Adeno-associated virus-based vectors in gene therapy
JP2022530824A5 (cg-RX-API-DMAC7.html)
JP6824169B2 (ja) 改変g6pcをコードするアデノ随伴ウイルスベクターおよびその使用
JP2022531861A5 (cg-RX-API-DMAC7.html)
WO2015196179A1 (en) Methods of packaging multiple adeno-associated virus vectors
JP2022046792A (ja) 組織特異的発現のための改変u6プロモーターシステム
CA2919103A1 (en) Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
JP2022530095A5 (cg-RX-API-DMAC7.html)
JP2022530833A5 (cg-RX-API-DMAC7.html)
JP2022553406A5 (cg-RX-API-DMAC7.html)
WO2020142714A1 (en) Aav expression cassette and aav vectors comprising the same
US12553063B2 (en) CAS13 family AAV vectors and uses thereof
CN110770344A (zh) shRNA表达框、携带其的多核苷酸序列及其应用
US20230346978A1 (en) Dcas13-mediated therapeutic rna base editing for in vivo gene therapy
Snyder et al. Viral vector-mediated gene transfer for CNS disease
CN112041437A (zh) 用于恢复f8基因功能的腺相关病毒组合物和其使用方法
JP2024546578A5 (cg-RX-API-DMAC7.html)
RU2716999C1 (ru) Способ получения рекомбинантных аденоассоциированных вирусов для использования в генной терапии
JP2024529279A (ja) Rbm20変異のゲノム編集